We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$218M
AUM Growth
+$661K
Cap. Flow
-$23.6M
Cap. Flow %
-10.83%
Top 10 Hldgs %
42.05%
Holding
929
New
3
Increased
17
Reduced
215
Closed
452

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.32M
2
CVX icon
Chevron
CVX
+$1.25M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.2M
4
LLY icon
Eli Lilly
LLY
+$562K
5
JPM icon
JPMorgan Chase
JPM
+$553K

Sector Composition

Rank Sector Weight
1 Technology 46.32%
2 Healthcare 10.53%
3 Consumer Staples 7.26%
4 Industrials 5.97%
5 Financials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBLX icon
451
Roblox
RBLX
$34B
$229 ﹤0.01%
5
EGRX
452
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$209 ﹤0.01%
40
VYX icon
453
NCR Voyix
VYX
$1.06B
$203 ﹤0.01%
12
-8
-40% -$128
PCG icon
454
PG&E
PCG
$47.8B
$198 ﹤0.01%
11
NATL icon
455
NCR Atleos
NATL
$3.52B
$146 ﹤0.01%
+6
New +$137
SPHD icon
456
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
$127 ﹤0.01%
3
VTRS icon
457
Viatris
VTRS
$20.1B
$116 ﹤0.01%
11
-880
-99% -$8.43K
VEU icon
458
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$112 ﹤0.01%
2
GAIA icon
459
Gaia
GAIA
$47.3M
$108 ﹤0.01%
40
+20
+100% +$54
VTEB icon
460
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$102 ﹤0.01%
2
AGEN
461
Agenus
AGEN
$249M
$83 ﹤0.01%
5
CHRN
462
ChronoScale Holdings
CHRN
$3.12B
$78 ﹤0.01%
2
CNDT icon
463
Conduent
CNDT
$230M
$73 ﹤0.01%
20
TVRD
464
Tvardi Therapeutics
TVRD
$23.5M
$59 ﹤0.01%
2
OGN icon
465
Organon & Co
OGN
$3.55B
$46 ﹤0.01%
3
-10
-77% -$136
RLMD icon
466
Relmada Therapeutics
RLMD
$544M
$25 ﹤0.01%
6
GTBP icon
467
GT Biopharma
GTBP
$11.7M
$15 ﹤0.01%
2
RAD
468
DELISTED
Rite Aid Corporation
RAD
$11 ﹤0.01%
50
CRDF icon
469
Cardiff Oncology
CRDF
$64.3M
$3 ﹤0.01%
2
MBOT icon
470
Microbot Medical
MBOT
$115M
$2 ﹤0.01%
1
ABNB icon
471
Airbnb
ABNB
$83.7B
-147
Closed -$20.2K
ACGL icon
472
Arch Capital
ACGL
$36.1B
-66
Closed -$5.26K
ACHC icon
473
Acadia Healthcare
ACHC
$3.17B
-77
Closed -$5.41K
ADC icon
474
Agree Realty
ADC
$9.68B
-84
Closed -$4.66K
AIG icon
475
American International
AIG
$41.9B
-89
Closed -$5.39K

Similar funds

Front Row Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Front Row Advisors held 929 positions worth $218M, up 0.3% from $217M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Front Row Advisors withdrew a net $23.6M in Q4 2023, closing 452 positions and reducing 215 holdings. Its most notable exit was Vanguard Information Technology ETF, an estimated $416K position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Front Row Advisors opened a new position in GitLab worth $12.6K.

  • Front Row Advisors's largest Q4 2023 buy was GitLab: 200 shares worth $12.6K.
  • Front Row Advisors added most to Pacer US Cash Cows 100 ETF in Q4 2023, an estimated $30.8K increase.
  • Front Row Advisors's biggest Q4 2023 reduction was ExxonMobil, cutting an estimated $1.32M.
  • Front Row Advisors fully exited Vanguard Information Technology ETF in Q4 2023, selling an estimated $416K.
  • Front Row Advisors's ten largest holdings make up 42% of its $218M portfolio in Q4 2023.
  • Front Row Advisors opened 3 new positions and closed 452 in Q4 2023.
  • Front Row Advisors's portfolio value rose 0.3% quarter-over-quarter to $218M.

Based on Front Row Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.